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In recent decades, verbal autopsy (VA) methods have
been increasingly used to identify likely causes of death
in settings where the majority of deaths occur without
medical attention or certification as to cause [1]. Devel-
opments in the 1980s and 1990s advanced the concep-
tual and methodological aspects of the science
considerably but fell short of providing a clear message
about best practices for those who rely on VA data
[2-10]. There has been a hiatus of methodological devel-
opment since then, due in part to persistent, narrow
assumptions as to the desire and need for cause of
death data and unrealistic evaluation standards. This has
not limited the application of VA methods in the
world’s poorest settings, but it has almost certainly lim-
ited the usefulness and comparability of the data. There
remains scarce evidence on which to base choice of
methods at the various stages of the VA data process.
However, the first ever Global Congress on Verbal
Autopsy, held in Bali, Indonesia in February 2011, repre-
sents a resurgence of methodological and conceptual
developments - VA is arguably one of the most impor-
tant fields in global health today.
Methodological development in recent years, particu-
larly in relation to probabilistic interpretation of VA
data, has brought VA into an exciting era that is creat-
ing new opportunities for reliable, timely, and useful
cause-specific mortality measurement. A shift away from
limited individual-level and clinical paradigms towards
population-based epidemiological thinking and public
health utility has been characterized by a flurry of new
methodological thinking and innovations from relatively
small groups of researchers. Among these like-minded
researchers, however, there is risk of a divide between
pragmatic optimists and optimistic theorists. The prag-
matic optimists are driven by the realities, perils, and
pitfalls of real-life health measurement in low-income
settings and strive to enhance health knowledge with
methods that are good enough to fill data gaps reliably
and efficiently. The optimistic theorists, whose metho-
dological developments are often theoretically superior,
are often far from offering practical solutions to those
on the ground who need to know the major burdens of
cause-specific mortality in their populations simply,
quickly, and cheaply in the absence of pre-existing data
and where “true validity” is difficult to establish. Such
dichotomization is perhaps somewhat artificial, but
there is a real risk that unrealistic standards and expec-
tations in method development and evaluation will
become the enemy of good enough methods that are
able to provide essential data to those who need it.
The Global Congress on VA was attended by over 100
delegates representing numerous agencies and academic
institutions from around the globe. This level of partici-
pation illustrates not only the persistent desire to know
w h od i e df r o mw h a ti nt h ew o r l d ’s poorest settings, but
also a desire for clear leadership on what the best meth-
ods are and how to use them. Whilst methodological
favoritism, ideology, and competition can be a threat to
an objective answer to this question, such factors are, in
reality, likely to be minor and secondary to the more
fundamental difficulty of recognizing the range of users
who need cause of death data and what data they need.
Differing cause of death data needs have been well
described previously and the nonexistence of a one-size-
fits-all solution to all needs is likely to persist [11]. This
statement is grounded in recognition of the realities of
health metrics in the world’s poorest populations and
the imperfect world of lay-reported signs and symptoms,
dubious record keeping, and biases in remembering,
reporting, and recording certain events. It is in recogni-
tion of these realities that the gap between the prag-
matic optimists and the optimistic theorists may grow:
the first believing that method development cannot
necessarily rely on pre-existing data and should be eval-
uated in terms of comparability to reference (but not
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any medium, provided the original work is properly cited.gold) standards, plausibility in relation to given knowl-
edge, and the ability to characterize population-level
cause-specific mortality well enough for the use of such
data for planning, monitoring, and evaluation; the latter
continuing on a quest for true validity, believing that
this does exist in relation to cause of death.
Validation is of course desirable for any method, but
do global cause of death gold standards for the valida-
tion of VA methods really exist? Hospital-based data
have been used in the past and continue to be used for
validation studies; however, deaths for which such data
are available are not representative of deaths in the
majority of individuals who live their lives, get sick, and
die with limited or no contact with formal health ser-
vices. Similarly, the symptom profiles of individuals who
die in the community in the absence of health care, or
at least the symptoms that are recalled and reported by
relatives of those individuals during VA interviews, are
likely to be considerably different from those who were
informed by contact with medical services. Even if
sophisticated methods attempt to adjust for this, the
c o s t so ft h i sa l c h e m ya r eh i g ha n dt h eg o l di sw i t h o u t
doubt alloyed, limiting its relevance for true commu-
nity-based populations and those who must plan ser-
vices for such populations. This fact does not mean that
such comparisons are not valuable to a certain extent -
they may highlight gross inconsistencies, for example.
A key achievement of the Bali congress was a “Bali
Declaration” that physician review of VA data as the
default method of choice for all VA interpretation
should be a thing of the past. On this, most experts
agreed, and this declaration represents a substantial step
forward, which will have untold implications for the
timeliness and utility of VA-derived cause of death data.
Such unity in communication on best practice in VA
methods from the world’s leaders in the field is timely
and commendable. The same unified voice on the best
method for VA interpretation that many might have
hoped to hear in Bali is not yet loud and clear, and
indeed better methods are likely to evolve over the com-
ing years. Before this can happen, however, there needs
to be agreement on flexibility in evaluation standards,
recognizing that the utility of a method is highly depen-
dent on who wants the data and what they want to do
with them. Single-mindedness with regards to absolute
measures of validity, true gold standards, and the utility
of data are likely to hinder ongoing developments in VA
at the expense of immediate public health benefits and
to the detriment of conceptual advances that have been
made in recent years.
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